Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
06 Nov 2025 |
On P&L |
The Company releases the press release related to the first nine months of 2025 financial results
|
Download |
|
06 Nov 2025 |
On P&L |
The Company releases the first nine months of 2025 financial results presentation
|
Download |
|
21 Oct 2025 |
On business and financial situation |
The Company releases the press release in relation to the announcement of the collaboration with Roche for the manufacture of a new medicine in development
|
Download |
|
29 Sep 2025 |
On corporate transactions: mergers, acquisitions and others |
ROVI announces the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA)
|
Download |
|
29 Sep 2025 |
On corporate transactions: mergers, acquisitions and others |
The Company releases the presentation related to the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA)
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
19 Apr 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 12 April and 18 April 2024
|
Download |
|
12 Apr 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 5 April and 11 April 2024
|
Download |
|
05 Apr 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 28 March and 4 April 2024
|
Download |
|
02 Apr 2024 |
On business and financial situation |
ROVI informs on the FDA’s approval of Risvan® as a treatment for schizophrenia
|
Download |
|
29 Mar 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 22 March and 27 March 2024
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
31 Jan 2020 |
R&D: new licenses, patents and registered trademarks |
The Company informs about the commencement of the assessment process to obtain marketing authorisation for Doria® in the European Union
|
Download |
|
08 Jan 2020 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the fourth quarter of 2019
|
Download |
|
20 Dec 2019 |
Composition of the board of directors |
The Company informs about the composition of its Board of Directors and its Audit and Appointments and Remuneration Committees.
|
Download |
|
24 Nov 2019 |
Strategic plans, profit forecasts and presentations |
The Company releases the presentation related to its strategy update because of the 2019 Investor Day.
|
Download |
|
07 Nov 2019 |
Information on P&L |
ROVI releases the press release related to the first nine months 2019 financial results
|
Download |
Pages
